Global disease experts say little is known about China's experience with long-term COVID effects thought to have afflicted millions with debilitating fatigue, brain fog and other symptoms
Pfizer and Moderna raise prices for COVID-19 vaccines in EU: FT
Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday.
Published : 1 August 2021, 12:46 PM
Updated : 1 August 2021, 12:46 PM
The new price for the Pfizer shot was 19.50 euros ($23.15)against 15.50 euros previously, the newspaper said, citing portions of the contracts seen.
The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from about 19 euros in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.
The European Commission said on Tuesday that the EU is on course to hit a target of fully vaccinating at least 70 percent of the adult population by the end of the summer.
In May, the EU said it expects to have received more than a billion doses of vaccines by the end of September from four drugmakers.
Pfizer and Moderna were not immediately available for comment to Reuters.
RELATED STORIES
The demonstrations helped to end COVID restrictions but failed to achieve lasting political change, six participants based in China and overseas say
The agency seeks details on an increase in respiratory illnesses and reported clusters of pneumonia in children, which its China office called a ‘routine’ check
The inquiry is examining the government's response to the coronavirus pandemic that shut large sections of the economy and killed more than 220,000 people in Britain
